{"id":3490,"date":"2025-07-12T05:53:07","date_gmt":"2025-07-12T05:53:07","guid":{"rendered":"https:\/\/www.newsbeep.com\/us\/3490\/"},"modified":"2025-07-12T05:53:07","modified_gmt":"2025-07-12T05:53:07","slug":"reli-cuts-debt-50-after-5m-fortman-sale-saves-1-8m-annually-soph-sec-filing","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/us\/3490\/","title":{"rendered":"RELI cuts debt 50% after $5M Fortman sale; saves $1.8M annually | SOPH SEC Filing"},"content":{"rendered":"<p style=\"margin: 0\">\u00a0<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">As filed with the Securities and Exchange Commission<br \/>\non July 11, 2025<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">\u00a0<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right\">Registration No. 333-__________<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right\">\u00a0<\/p>\n<p style=\"font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">UNITED STATES<\/p>\n<p style=\"font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">SECURITIES AND EXCHANGE COMMISSION<\/p>\n<p style=\"font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">Washington, D.C. 20549<\/p>\n<p style=\"font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">\u00a0<\/p>\n<p style=\"font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">FORM S-8<\/p>\n<p style=\"font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">\u00a0<\/p>\n<p style=\"font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">REGISTRATION STATEMENT UNDER<\/p>\n<p style=\"font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">THE SECURITIES ACT OF 1933<\/p>\n<p style=\"font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">\u00a0<\/p>\n<p style=\"font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">SOPHiA GENETICS SA<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">(Exact name of registrant as specified in its charter)<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">\u00a0<\/p>\n<p>    Switzerland<br \/>\n    \u00a0<br \/>\n    Not Applicable<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">(State or other jurisdiction of<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">incorporation or organization)<\/p>\n<p>    \u00a0<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">(I.R.S. Employer<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">Identification No.)<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">\u00a0<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">La Pi\u00e8ce 12, CH-1180 Rolle, Switzerland<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt\">(Address of Principal Executive Offices)<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0<\/p>\n<p style=\"text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\">SOPHiA<br \/>\nGENETICS SA 2021 Equity Incentive Plan <\/p>\n<p style=\"text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\">(Full title of the plan)<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">SOPHiA GENETICS, Inc.<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">401 Park Drive, Suite 505<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">Boston, MA 02215<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">(Name and Address of Agent For Service)<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">\u00a0<\/p>\n<p style=\"text-align: center; margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt\">(617) 982-1210<\/p>\n<p style=\"text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt\">(Telephone number, Including Area Code, of Agent For Service)<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">Copies of all communications, including all communications sent<br \/>\nto the agent for service, should be sent to:<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">Kyoko Takahashi Lin<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">Davis Polk &amp; Wardwell LLP<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">450 Lexington Avenue<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">New York, NY 10017<\/p>\n<p style=\"text-align: center; margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt\">(212) 450-4000<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">Indicate by check mark whether the registrant is a large accelerated<br \/>\nfiler, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of<br \/>\n\u201clarge accelerated filer,\u201d \u201caccelerated filer,\u201d \u201csmaller reporting company\u201d and \u201cemerging growth<br \/>\ncompany\u201d in Rule 12b-2 of the Exchange Act.<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0<\/p>\n<p>    Large accelerated filer o<br \/>\n    \u00a0<br \/>\n    Accelerated filer x<\/p>\n<p>    Non-accelerated filer o<br \/>\n    \u00a0<br \/>\n    Smaller reporting company o<\/p>\n<p style=\"margin-top: 0; margin-bottom: 0\">\u00a0<\/p>\n<p>    (Do not check if a smaller reporting company)<br \/>\n    \u00a0<br \/>\n    Emerging Growth Company x<\/p>\n<p style=\"margin-top: 0; margin-bottom: 0\">\u00a0<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">If an emerging growth company, indicate by check mark if the registrant<br \/>\nhas elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant<br \/>\nto Section 7(a)(2)(B) of the Securities Act. o<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">PART I<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">\u00a0<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in\">INFORMATION REQUIRED IN<br \/>\nTHE SECTION 10(a) PROSPECTUS<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in\">\u00a0<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in\">Pursuant to General Instruction E to Form S-8,<br \/>\nSOPHiA GENETICS SA (the \u201cRegistrant\u201d) is filing this Registration Statement on Form S-8 (this \u201cRegistration<br \/>\nStatement\u201d) with the U.S. Securities and Exchange Commission (the \u201cCommission\u201d) to register 15,693,055 additional<br \/>\nordinary shares, par value CHF 0.05 per share, of the Registrant (the \u201cShares\u201d), for issuance under the Registrant\u2019s<br \/>\n2021 Equity Incentive Plan. This Registration Statement hereby incorporates by reference the contents of the Registrant\u2019s registration<br \/>\nstatements on Form S-8 filed with the Commission on July 23, 2021 (Registration No. 333-258121). In accordance with the instructional<br \/>\nnote to Part I of Form S-8 as promulgated by the Commission, the information specified by Part I of Form S-8 has been omitted from this<br \/>\nRegistration Statement.<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in\">\u00a0<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in\">PART II<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in\">\u00a0<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in\">INFORMATION REQUIRED IN<br \/>\nTHE REGISTRATION STATEMENT<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in\">\u00a0<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">Item 3. Incorporation of Documents by Reference.<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">The following documents are incorporated herein by reference:<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0<\/p>\n<p>(a)The latest Registrant\u2019s Form 20-F filed with the Commission on March 04, 2025 (the \u201cForm 20-F\u201d) pursuant<br \/>\nto Section 13(a) or 15(d) of the Exchange Act (the \u201cExchange Act\u201d), which contains the Registrant\u2019s audited financial<br \/>\nstatements for the latest fiscal year for which such statements have been filed (File No. 001-40627);<\/p>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0<\/p>\n<p>(b)The Registrant\u2019s Current Report on Form 6-K, filed with the SEC on May 6, 2025 (other than Exhibit 99.3 thereto) (File No. 001-40627);<br \/>\nand<\/p>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0<\/p>\n<p>(c)The description of the Registrant\u2019s share capital which is included as Exhibit 2.1 to the Form 20-F, including any amendment<br \/>\nor supplements thereto.<\/p>\n<p style=\"margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif\">\u00a0<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">In addition, all documents subsequently filed by the Registrant with<br \/>\nthe Commission pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act, prior to the filing of a post-effective amendment<br \/>\nto this Registration Statement which indicates that all securities offered have been sold or which deregisters all securities then remaining<br \/>\nunsold, including any Reports of Foreign Private Issuers on Form 6-K submitted during such period (or portion thereof) that is identified<br \/>\nin such form as being incorporated by reference into this Registration Statement, shall be deemed to be incorporated by reference in this<br \/>\nRegistration Statement and to be a part hereof from the date of the filing of such documents. The Registrant is not incorporating by reference<br \/>\nany documents or portions thereof, whether specifically listed above or filed in the future, that are not deemed \u201cfiled\u201d with<br \/>\nthe Commission.<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">Any statement contained in a document incorporated or deemed to be<br \/>\nincorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent<br \/>\nthat a statement contained herein, (or in any other subsequently filed document which also is incorporated or deemed to be incorporated<br \/>\nby reference herein), modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except<br \/>\nas so modified or superseded, to constitute a part of this Registration Statement.<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">Item 8. Exhibits.<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border-bottom: black 0.5pt solid\">Exhibit Number<\/p>\n<p>    \u00a0<\/p>\n<p>    4<br \/>\n    Amended Articles of Association of SOPHiA GENETICS SA (incorporated herein by reference to Exhibit 99.1 to the Registrant\u2019s Form 6-K, filed on June 18, 2025)<\/p>\n<p>    \u00a0<br \/>\n    \u00a0<\/p>\n<p>    5<br \/>\n    Opinion of Niederer Kraft Frey Ltd., Swiss counsel of SOPHiA GENETICS SA (filed herewith)<\/p>\n<p>    \u00a0<br \/>\n    \u00a0<\/p>\n<p>    23.1<br \/>\n    Consent of PricewaterhouseCoopers SA, independent registered public accounting firm (filed herewith)<\/p>\n<p>    \u00a0<br \/>\n    \u00a0<\/p>\n<p>    23.2<br \/>\n    Consent of Niederer Kraft Frey Ltd.,Swiss counsel of SOPHiA GENETICS SA (included in Exhibit 5)<\/p>\n<p>    \u00a0<br \/>\n    \u00a0<\/p>\n<p>    24<br \/>\n    Powers of Attorney (included in the signature pages hereto)<\/p>\n<p>    \u00a0<br \/>\n    \u00a0<\/p>\n<p>    99.1<br \/>\n    SOPHiA GENETICS SA 2021 Equity Incentive Plan (incorporated herein by reference to Exhibit 10.13 to the Registrant\u2019s Registration Statement on Form F-1, filed on July 2, 2021)<\/p>\n<p>    \u00a0<br \/>\n    \u00a0<\/p>\n<p>    107<br \/>\n    Filing Fee Table (filed herewith)<\/p>\n<p style=\"margin-top: 0; margin-bottom: 0\">\u00a0<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">SIGNATURES<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">\u00a0<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in\">Pursuant to the requirements of the Securities<br \/>\nAct of 1933, as amended (the \u201cSecurities Act\u201d), the Registrant certifies that it has reasonable grounds to believe<br \/>\nthat it meets all of the requirements for filing this Registration Statement and has duly caused this Registration Statement to be signed<br \/>\non its behalf by the undersigned, thereunto duly authorized, in the municipality of Rolle, Switzerland on July 11,<br \/>\n2025.<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in\">\u00a0<\/p>\n<p>    \u00a0<br \/>\n    SOPHiA GENETICS SA<br \/>\n    \u00a0<\/p>\n<p>    \u00a0<br \/>\n    \u00a0<br \/>\n    \u00a0<\/p>\n<p>    \u00a0<br \/>\n    \u00a0<br \/>\n    \u00a0<\/p>\n<p>    \u00a0<br \/>\n    By:<br \/>\n    \/s\/ Ross Muken<br \/>\n    \u00a0<\/p>\n<p>    \u00a0<br \/>\n    Name:<br \/>\n    Ross Muken<br \/>\n    \u00a0<\/p>\n<p>    \u00a0<br \/>\n    Title:<br \/>\n    President<br \/>\n    \u00a0<\/p>\n<p style=\"margin-top: 0; margin-bottom: 0\">\u00a0<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">POWER OF ATTORNEY<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center\">\u00a0<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature<br \/>\nappears below hereby constitutes and appoints Jurgi Camblong, Ross Muken and Daan van Well and each of them, individually, as his or her<br \/>\ntrue and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her and in his or her name,<br \/>\nplace and stead, in any and all capacities, in connection with this registration statement, including to sign in the name and on behalf<br \/>\nof the undersigned, this Registration Statement and any and all amendments thereto, including post-effective amendments and registrations<br \/>\nfiled pursuant to Rule 462 under the Securities Act, as amended, and to file the same, with all exhibits thereto, and other documents<br \/>\nin connection therewith, with the U.S. Securities and Exchange Commission, granting unto each such attorney-in-fact and agent full power<br \/>\nand authority to do and perform each and every act in person, hereby ratifying and confirming all that each said attorney-in-fact and<br \/>\nagent, or his or her substitutes, may lawfully do or cause to be done by virtue hereof. Pursuant to the requirements of the Securities<br \/>\nAct, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.<\/p>\n<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">\u00a0<\/p>\n<p>    Signature<br \/>\n    \u00a0<br \/>\n    Title<br \/>\n    Date<\/p>\n<p>    \u00a0<br \/>\n    \u00a0<br \/>\n    \u00a0<br \/>\n    \u00a0<\/p>\n<p>    \/s\/ Jurgi Camblong<br \/>\n    \u00a0<br \/>\n    Chief Executive Officer and Director<br \/>\n    July 11,<br \/>\n2025<\/p>\n<p>    Jurgi Camblong<br \/>\n    \u00a0<br \/>\n    (Principal Executive Officer)<br \/>\n    \u00a0<\/p>\n<p>    \u00a0<br \/>\n    \u00a0<br \/>\n    \u00a0<br \/>\n    \u00a0<\/p>\n<p>    \/s\/ George Cardoza<br \/>\n    \u00a0<br \/>\n    Chief Financial Officer<br \/>\n    July 11,<br \/>\n2025<\/p>\n<p>    George Cardoza<br \/>\n    \u00a0<br \/>\n    (Principal Financial and Accounting Officer)<br \/>\n    \u00a0<\/p>\n<p>    \u00a0<br \/>\n    \u00a0<br \/>\n    \u00a0<br \/>\n    \u00a0<\/p>\n<p>    \/s\/ Troy Cox<br \/>\n    \u00a0<br \/>\n    \u00a0<br \/>\n    July 11,<br \/>\n2025<\/p>\n<p>    Troy Cox<br \/>\n    \u00a0<br \/>\n    Chairman of the Board of Directors<br \/>\n    \u00a0<\/p>\n<p>    \u00a0<br \/>\n    \u00a0<br \/>\n    \u00a0<br \/>\n    \u00a0<\/p>\n<p>    \/s\/ Tomer Berkovitz\u00a0<br \/>\n    \u00a0<br \/>\n    \u00a0<br \/>\n    July 11,<br \/>\n2025<\/p>\n<p>    Tomer Berkovitz<br \/>\n    \u00a0<br \/>\n    Director<br \/>\n    \u00a0<\/p>\n<p>    \u00a0<br \/>\n    \u00a0<br \/>\n    \u00a0<br \/>\n    \u00a0<\/p>\n<p>    \/s\/ Kathy Hibbs<br \/>\n    \u00a0<br \/>\n    \u00a0<br \/>\n    July 11,<br \/>\n2025<\/p>\n<p>    Kathy Hibbs<br \/>\n    \u00a0<br \/>\n    Director<br \/>\n    \u00a0<\/p>\n<p>    \u00a0<br \/>\n    \u00a0<br \/>\n    \u00a0<br \/>\n    \u00a0<\/p>\n<p>    \/s\/ Didier Hirsch<br \/>\n    \u00a0<br \/>\n    \u00a0<br \/>\n    July 11,<br \/>\n2025<\/p>\n<p>    Didier Hirsch<br \/>\n    \u00a0<br \/>\n    Director<br \/>\n    \u00a0<\/p>\n<p>    \u00a0<br \/>\n    \u00a0<br \/>\n    \u00a0<br \/>\n    \u00a0<\/p>\n<p>    \/s\/ Vincent Ossipow<br \/>\n    \u00a0<br \/>\n    \u00a0<br \/>\n    July 11,<br \/>\n2025<\/p>\n<p>    Vincent Ossipow<br \/>\n    \u00a0<br \/>\n    Director<br \/>\n    \u00a0<\/p>\n<p>    \u00a0<br \/>\n    \u00a0<br \/>\n    \u00a0<br \/>\n    \u00a0<\/p>\n<p>    \/s\/ Jean-Michel Coss\u00e9ry<br \/>\n    \u00a0<br \/>\n    \u00a0<br \/>\n    July 11,<br \/>\n2025<\/p>\n<p>    Jean-Michel Coss\u00e9ry<br \/>\n    \u00a0<br \/>\n    Director<br \/>\n    \u00a0<\/p>\n<p>    \u00a0<br \/>\n    \u00a0<br \/>\n    \u00a0<br \/>\n    \u00a0<\/p>\n<p>    \/s\/ Ross Muken<br \/>\n    \u00a0<br \/>\n    \u00a0<br \/>\n    July 11,<br \/>\n2025<\/p>\n<p>    Ross Muken<br \/>\n    \u00a0<br \/>\n    President, Authorized Representative in the United States<br \/>\n    \u00a0<\/p>\n<p style=\"margin-top: 0; margin-bottom: 0\">\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"\u00a0 As filed with the Securities and Exchange Commission on July 11, 2025 \u00a0 Registration No. 333-__________ \u00a0&hellip;\n","protected":false},"author":2,"featured_media":3491,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[50],"tags":[4071,4069,4070,4068,200,4072,4066,4065,4067,79],"class_list":{"0":"post-3490","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-genetics","8":"tag-5m-divestiture","9":"tag-debt-reduction","10":"tag-form-8-k","11":"tag-fortman-sale","12":"tag-genetics","13":"tag-interest-savings","14":"tag-reli","15":"tag-reliance-global-group","16":"tag-reliw","17":"tag-science"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/3490","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/comments?post=3490"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/3490\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media\/3491"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media?parent=3490"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/categories?post=3490"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/tags?post=3490"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}